# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3625861 | B | Inhibition of muscarinic receptor (unknown origin) | Homo sapiens | 4 | assay format | Scientific Literature | ||
2. | ALA3625862 | B | Inhibition of dopamine receptor (unknown origin) | Homo sapiens | 4 | protein format | Scientific Literature | ||
3. | ALA3625863 | B | Inhibition of serotonin receptor (unknown origin) | Homo sapiens | 4 | assay format | Scientific Literature | ||
4. | ALA3625864 | B | Inhibition of histamine receptor (unknown origin) | Homo sapiens | 4 | assay format | Scientific Literature | ||
5. | ALA3625865 | F | Antitrypanosomal activity against Trypanosoma brucei brucei GVR35 infected in NMRI mouse model of stage-2 human African trypanosomiasis assessed as infection relapse on day 6 to day 13 post infection at 15 mg/kg, ip bid for 5 days starting from 21 days post infection | Trypanosoma brucei brucei | 1 | organism-based format | Scientific Literature | ||
6. | ALA3625867 | T | Toxicity in Trypanosoma brucei brucei S427 infected NMRI mouse model of stage-1 human African trypanosomiasis assessed as induction if clinical signs of toxicity at 25 mg/kg, ip bid administered as single dose | Mus musculus | 1 | organism-based format | Scientific Literature | ||
7. | ALA3625868 | T | Toxicity in Trypanosoma brucei brucei S427 infected NMRI mouse model of stage-1 human African trypanosomiasis dosed intraperitoneally twice per day for 3 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
8. | ALA3625869 | F | Antitrypanosomal activity against Trypanosoma brucei brucei BSF427 VSG118 bloodstream forms incubated for 69 hrs by resazurin dye based assay | Trypanosoma brucei brucei | 53 | organism-based format | Scientific Literature | ||
9. | ALA3625870 | A | Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 69 hrs by resazurin dye based assay | Homo sapiens | 53 | cell-based format | Scientific Literature | ||
10. | ALA3625871 | A | Intrinsic clearance in CD1 mouse liver microsomes incubated for 3 to 30 mins in presence of NADPH by UPLC/MS/MS method | Mus musculus | 45 | assay format | Scientific Literature | ||
11. | ALA3625873 | A | Intrinsic clearance in pooled mixed gender human liver microsomes incubated for 3 to 30 mins in presence of NADPH by UPLC/MS/MS method | Homo sapiens | 29 | assay format | Scientific Literature | ||
12. | ALA3625874 | T | Selectivity index, ratio of EC50 for cytotoxicty against human MRC5 cells to EC50 for antitrypanosomal activity against Trypanosoma brucei brucei BSF427 VSG118 bloodstream forms | 5 | cell-based format | Scientific Literature | |||
13. | ALA3625875 | P | Solubility of the compound | 5 | small-molecule physicochemical format | Scientific Literature | |||
14. | ALA3625876 | A | Fraction unbound in mouse plasma | Mus musculus | 4 | cell-free format | Scientific Literature | ||
15. | ALA3625878 | A | Fraction unbound in NMRI mouse brain at 0.5 to 1 free base/kg, iv by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
16. | ALA3626003 | A | Cmax in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
17. | ALA3626004 | A | Tmax in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
18. | ALA3626005 | A | AUC (0 to 8 hrs) in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
19. | ALA3626006 | A | Half life in NMRI mouse at 10 mg free base/kg, ip by UPLC/MS/MS method | Mus musculus | 5 | organism-based format | Scientific Literature | ||
20. | ALA3626007 | A | Ratio of drug level in brain to blood in NMRI mouse at 0.5 and 1 mg free base/kg, iv after 5 mins by UPLC/MS/MS method | Mus musculus | 4 | organism-based format | Scientific Literature |